2 studies on IL-1β mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**KPV and KdPT reframe the anti-inflammatory potential of α-MSH by stripping it down to a receptor-independent, pigmentation-free tripeptide** — a meaningful leap for any clinician or researcher frustrated by full-hor…
This research provides a more granular understanding of Semax's mechanism of action in a neuroprotective context, specifically linking its benefits to the downregulation of a precise set of inflammatory genes. For ind…